Trial Profile
Detection rates of 68Ga-PSMA PET/CT in patients with biochemical recurrence after definitive treatment of Prostate Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Nov 2016
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 25 Nov 2016 New trial record
- 01 Oct 2016 Results published in the BJU International